Gene · 84447
Papers1,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| E3 ubiquitin ligase SYVN1 as a promising therapeutic target for diverse human diseases. | Pharmacol Res | 2025 | 39818260 | PubTator, text mining | PubMed |
| Activation of the 26S Proteasome to Reduce Proteotoxic Stress and Improve the Efficacy of PROTACs. | ACS Pharmacol Transl Sci | 2025 | 39816802 | PubTator, text mining | PubMed |
| Icariin improves learning and memory function by enhancing HRD1-mediated ubiquitination of amyloid precursor protein in APP/PS1 mice. | J Alzheimers Dis | 2025 | 39814545 | PubTator, text mining | PubMed |
| Gain of pancreatic beta cell-specific SCD1 improves glucose homeostasis by maintaining functional beta cell mass under metabolic stress. | Diabetologia | 2025 | 39690249 | PubTator, text mining | PubMed |
| Elucidation of the late steps in the glycan-dependent ERAD of soluble misfolded glycoproteins. | Plant J | 2025 | 39642157 | PubTator, text mining | PubMed |
| H. Pylori-Facilitated TERT/Wnt/β-Catenin Triggers Spasmolytic Polypeptide-Expressing Metaplasia and Oxyntic Atrophy. | Adv Sci (Weinh) | 2025 | 39587848 | PubTator, text mining | PubMed |
| Role of SEL1L in the progression of solid tumors, with a special focus on its recent therapeutic potential. | Cell Biol Int | 2025 | 39364680 | PubTator, text mining | PubMed |
| Phosphofructokinase-1 in Cancer: A Promising Target for Diagnosis and Therapy. | Recent Pat Anticancer Drug Discov | 2025 | 39171598 | PubTator, text mining | PubMed |
| Astragaloside IV Overcomes Anlotinib Resistance in Non-small Cell Lung Cancer through miR-181a-3p/UPR-ERAD Axis. | Curr Comput Aided Drug Des | 2025 | 38310574 | PubTator, text mining | PubMed |
| Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity. | Sci Immunol | 2024 | 39546589 | PubTator, text mining | PubMed |
| IGFBP6 Modulates Proteostasis by Activating ATF4 Targets and Reducing ER Retrotranslocon Expression. | Dokl Biochem Biophys | 2024 | 39480639 | PubTator, text mining | PubMed |
| Regulation of hepatic inclusions and fibrinogen biogenesis by SEL1L-HRD1 ERAD. | Nat Commun | 2024 | 39455574 | PubTator, text mining | PubMed |
| Post-Translational Modifications of RNA-Modifying Proteins in Cellular Dynamics and Disease Progression. | Adv Sci (Weinh) | 2024 | 39377984 | PubTator, text mining | PubMed |
| Purkinje cell-specific deficiency in SEL1L-hrd1 endoplasmic reticulum-associated degradation causes progressive cerebellar ataxia in mice. | JCI Insight | 2024 | 39352758 | PubTator, text mining | PubMed |
| Regulation of leptin signaling and diet-induced obesity by SEL1L-HRD1 ER-associated degradation in POMC expressing neurons. | Nat Commun | 2024 | 39343970 | PubTator, text mining | PubMed |
| ER-associated degradation ligase HRD1 links ER stress to DNA damage repair by modulating the activity of DNA-PKcs. | Proc Natl Acad Sci U S A | 2024 | 39226359 | PubTator, text mining | PubMed |
| cirSIRT5 induces ferroptosis in bladder cancer by forming a ternary complex with SYVN1/PHGDH. | Cell Death Discov | 2024 | 39223162 | PubTator, text mining | PubMed |
| Endoplasmic reticulum associated degradation preserves neurons viability by maintaining endoplasmic reticulum homeostasis. | Front Neurosci | 2024 | 39135735 | PubTator, text mining | PubMed |
| Characterization of PANoptosis-related genes with immunoregulatory features in osteoarthritis. | Int Immunopharmacol | 2024 | 39128418 | PubTator, text mining | PubMed |
| The HRD1-SEL1L ubiquitin ligase regulates stress granule homeostasis in couple with distinctive signaling branches of ER stress. | iScience | 2024 | 38979013 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84447/papers?page=6